ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients (Q35937633)

11 August 2017

ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients (English)

1 reference

11 August 2017

S Y Han

1

1 reference

11 August 2017

Y J Kwon

2

1 reference

11 August 2017

S K Jo

3

1 reference

11 August 2017

J H Shin

4

1 reference

11 August 2017

D R Cha

5

1 reference

11 August 2017

W Y Cho

6

1 reference

11 August 2017

H J Pyo

7

1 reference

11 August 2017

H K Kim

8

1 reference

11 August 2017

1 January 2000

1 reference

The Korean journal of internal medicine

11 August 2017

1 reference

11 August 2017

15

1 reference

11 August 2017

1

1 reference

11 August 2017

13-18

1 reference

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

Systemic hypertension versus intraglomerular hypertension in progression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

The commonest glomerulonephritis in the world: IgA nephropathy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

Kinin contribution to renal vasodilator effect of captopril in rabbit

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4531733

Angiotensin-converting enzyme polymorphism in patients with terminal renal failure

24 September 2018

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group

1 reference

12 December 2020

Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition

1 reference

12 December 2020

Angiotensin II as a renal growth factor

1 reference

12 December 2020

Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy

1 reference

12 December 2020

Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria

1 reference

12 December 2020

Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy

1 reference

12 December 2020

No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis

1 reference

12 December 2020

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy

1 reference

12 December 2020

Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease

1 reference

12 December 2020

Polymorphisms of the renin-angiotensin system genes in progressive renal diseases

1 reference

12 December 2020

Deterioration Rate in Hypertensive IgA Nephropathy: Comparison of a Converting Enzyme Inhibitor and β-Blocking Agents

1 reference

12 December 2020

10.3904/KJIM.2000.15.1.13

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

10714086

1 reference